The COVID-19 pandemic has disrupted clinical operations and accelerated much-needed change, according to a new survey conducted by Informa Pharma Intelligence on behalf of Oracle Health Sciences. With patients unable to physically visit clinical trial sites, 76% of survey respondents noted that the pandemic sped their adoption of decentralized clinical trial methods. The same percentage (76%) reported at least some of their trials have already been decentralized, and 38% indicated more than half are decentralized. But despite this momentum, respondents said concerns remain around decentralized trial data collection and quality, as well as regulatory guidance.
“The pandemic will have a profound and lasting effect on clinical trials,” said Henry McNamara, senior vice president and general manager, Oracle Health Sciences. “The survey results illustrate how quickly the industry has pivoted and adopted new approaches, such as decentralized clinical trial methods, to keep clinical research going in these unprecedented times. Fortunately, our technology supports this change today and is designed to carry the industry forward.”
The Accelerated Evolution of Clinical Trials in a Pandemic Environment survey, which was conducted from September 21 through November 11, 2020, gathered data from 252 respondents representing professionals from biopharmaceutical companies, CROs, and medical device companies involved in the operation and management of clinical trials. The respondents were located primarily in North America and Europe, with some representation from the Asia Pacific and the rest of the world.
To learn more and download the full report, click here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.